The Trump administration's plan to offer cheaper obesity drugs to seniors via a Medicare pilot program is encountering significant challenges.
Health insurers are reportedly concerned about the financial implications of participating in this initiative, which may strain their resources.
As discussions continue, the future of this program remains uncertain, highlighting the complexities involved in expanding access to obesity treatments for seniors.
Updates
Update at 13:38 UTC on 2026-04-22
STAT reported The Trump administration has dropped a plan for insurers to provide cheap weight loss drugs to seniors through a Medicare pilot program.
Sources: STAT